eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 04/05/2011
SPC Boots Derma Care Hydrocortisone 1% Ointment


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Boots Derma Care Hydrocortisone 1% Ointment


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

% w/w

Hydrocortisone Ph Eur

1.0


Go to top of the page
3. PHARMACEUTICAL FORM

Ointment


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

POM: For the treatment of mild to moderate inflammatory skin disorders such as eczema, including atopic, infantile, discoid and stasis eczema; seborrhoeic dermatitis, intertrigo, otitis externa, contact dermatitis, neurodermatitis flexural psoriasis and lichen simplex.

P: For the relief of irritant contact dermatitis, allergic contact dermatitis, insect bite reactions and mild to moderate eczema.


Go to top of the page
4.2 Posology and method of administration

POM: For adults and children: Apply sparingly twice a day.

P: For adults, the elderly and children over 10 years of age: Apply sparingly to a small area, once or twice a day, for a maximum of 7 days.

Children under 10 years of age: Not recommended except under medical supervision.

For topical application.


Go to top of the page
4.3 Contraindications

POM: Should not be used if allergic to any of the ingredients or on untreated, infected lesions, ulcerative conditions, rosacea, peri-oral dermatitis or acne.

P: The product should not be used if allergic to any of the ingredients or on the eyes or face, the ano-genital area or on broken or infected skin including impetigo, cold sores, acne or athlete's foot.


Go to top of the page
4.4 Special warnings and precautions for use

POM: Avoid prolonged, continuous use, particularly in children and especially on the face, as adrenal suppression may occur.

P: Medical advice should be sought if the condition does not improve.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

P and POM: No clinically significant interactions known.


Go to top of the page
4.6 Pregnancy and lactation

POM: There is inadequate evidence of safety in human pregnancy. Topical application of corticosteroids to pregnant animals can cause abnormalities of foetal development. There may, therefore, be a very small risk of such effects in the human foetus.

P: This product should not be used in pregnancy without medical advice. There is no information about effects during lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

P and POM: No adverse effects known.


Go to top of the page
4.8 Undesirable effects

POM: The product is usually well tolerated, but if hypersensitivity occurs use of the product should be discontinued.

Epidermal thinning, telangectasia and striae may occur in areas of high absorption such as skin folds, the face and the nappy area and where occlusive dressings are used. Sufficient systemic absorption may occur at these sites to produce features of suppression of the HPA (hypothalamo-pituitary-adrenal) axis after prolonged treatment.

P: Hydrocortisone Ointment 1% is usually well tolerated but if hypersensitivity occurs discontinue use.


Go to top of the page
4.9 Overdose

POM: Acute overdosage is very unlikely to occur. In the case of chronic overdosage or misuse the features of hypercorticism may appear and in this situation, topical steroids should be discontinued.

P: No special precautions or antidotes are likely to be needed.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Hydrocortisone is a corticosteroid which has antiinflammatory activity.


Go to top of the page
5.2 Pharmacokinetic properties

Following topical application to most areas of normal skin, only minimal amounts of the drug reach the dermis and subsequently the systemic circulation. Absorption may be markedly increased when the skin has lost its keratin layer and can be increased by inflammation or diseases of the epidermal barrier. Hydrocortisone is absorbed to a greater degree from the scrotum, axilla, eyelid, face and scalp than from the forearm, knee, elbow, palm and sole.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

White soft paraffin.


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

P: 15 gram internally lacquered, collapsible, aluminium tubes with polypropylene caps. The tubes are packed into cartons.

POM: 15, 30 and 50 gram internally lacquered, collapsible, aluminium tubes with polypropylene caps. The tubes are packed into cartons.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

Trading as: BCM


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/0364.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

14 April 1987 / 17 June 1997


Go to top of the page
10. DATE OF REVISION OF THE TEXT

May 2010



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/11996/SPC/


Active Ingredients/Generics

 
   hydrocortisone